Publications
Knowledge generated at IrsiCaixa is shared with the scientific community through the publication of articles in high impact scientific journals.
Anti-SARS-CoV-2 hyperimmune globulin demonstrates potent neutralization and antibody-dependent cellular cytotoxicity and phagocytosis through N and S proteins.
Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes
Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals.
SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells.
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity.
Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses.
Mouthwashes with CPC Reduce the Infectivity of SARS-CoV-2 Variants In Vitro.
First Detection of SARS-CoV-2 Delta (B.1.617.2) Variant of Concern in a Dog with Clinical Signs in Spain.
PSGL-1 restricts HIV-1 infectivity by blocking virus particle attachment to target cells.